Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.
about
A novel EGFR-TKI inhibitor (cAMP-H3BO3complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes.The reality of complexity: concomitant genomic alterations in patients with EGFR mutations.Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
P2860
Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@ast
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@en
type
label
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@ast
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@en
prefLabel
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@ast
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Concurrent gene alterations wi ...... th non-small cell lung cancer.
@en
P2093
P2860
P304
25046-25054
P356
10.18632/ONCOTARGET.15337
P407
P577
2017-02-15T00:00:00Z